Barzin Y. Nabet

机构：Gene Therapy Laboratory · ORCID：0000-0002-4824-3533

发表论文 190 篇 · 总被引 8519 次 · h-index 31

代表论文

VEGF-A blockade overcomes liver metastases resistance to chemoimmunotherapy in patients with advanced non-squamous NSCLC (2026 · Journal for ImmunoTherapy of Cancer · 被引 1)
Transcriptomic analyses of molecular subsets and correlations with clinical outcomes from the phase 3 IMforte study of lurbinectedin (lurbi) + atezolizumab (atezo) maintenance treatment (Tx) in extensive-stage small-cell lung cancer (ES-SCLC). (2026 · Journal of Clinical Oncology · 被引 1)
Automated measurement of CD8+ T-cell distribution at the tumor epithelial–stromal interface is associated with NSCLC immunotherapy benefit and transcriptomic pathways (2026 · Journal of Pathology Informatics)
Supplementary Figure S10 from T Cells Instruct Immune Checkpoint Inhibitor Therapy Resistance in Tumors Responsive to IL1 and TNFα Inflammation (2026)
Supplementary Figure S2 from T Cells Instruct Immune Checkpoint Inhibitor Therapy Resistance in Tumors Responsive to IL1 and TNFα Inflammation (2026)
Supplementary Figure S4 from T Cells Instruct Immune Checkpoint Inhibitor Therapy Resistance in Tumors Responsive to IL1 and TNFα Inflammation (2026)